CardioDx Receives $7,369,475 Series D Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f3b134bd-137f-494b-bb4b-a454db1dc2f7 - Date
2/23/2016 - Company Name
CardioDx - Mailing Address
600 Saginaw Drive Redwood City, CA 94063 USA - Company Description
Founded in 2004, CardioDx is a cardiovascular genomic diagnostics company. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. - Website
http://www.cardiodx.com - Transaction Type
Venture Equity - Transaction Amount
$7,369,475 - Transaction Round
Series D - Proceeds Purposes
Proceeds purposes were not disclosed. 15 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
